Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Genetic and Social Determinants of Renin-Angiotensin-Aldosterone System Inhibitor-Induced Angioedema: A Precision Medicine Health Equity Study

Open access

Abstract

Angioedema is a life-threatening adverse drug reaction associated with renin-angiotensin-aldosterone system (RAAS) inhibitors, characterized by localized swelling in the deep layers of the skin. Well-established evidence indicates an up to fivefold higher incidence of RAAS inhibitor-induced angioedema in self-identified Black patients compared to White patients. The mechanisms underlying this health disparity remain poorly understood and are often attributed to race, a poor proxy for interindividual genetic similarity and social stressors. Here, we investigate the genetic and social determinants of RAAS inhibitor-induced angioedema as well as the etiology of this racial difference. In particular, we (1) discovered OTULINL and CRABP1 as novel loci for RAAS inhibitor-induced angioedema, (2) confirmed the importance of bradykinin for this adverse drug reaction, (3) reported the first significant genome-wide association in self-identified Black participants, (4) identified alcohol use as an important social determinant, (5) demonstrated the strong role of variants enriched in 1000 Genomes African superpopulation-like genomes as the driver of racially differential angioedema risk, and (6) demonstrated the combined role of polygenic effect size and allele frequency differences in explaining these racial differences. Our results suggest that a clinical precision medicine tool may more precisely predict for whom RAAS inhibitors should be avoided (to prevent angioedema) compared to using race. These findings ultimately underscore the value of an evidence-based approach to removing race from treatment guidelines, which carries less potential harm than other removal strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.64898/2026.01.06.26343530

Cites

0 citation errors · 0 not checkable

Statistics

Figures

Extended Data Figure 1. Study inclusion and exclusion criteria for RAAS inhibitor-induced angioedema cases. AoURP, All of Us Research Program; GERA, Genetic Epidemiology Research in Adult Health and Aging; MVP, Million Veteran Program; RAAS, renin-angiotensin-aldosterone system. In the GERA cohort, the timing of RAAS inhibitor initiation was unavailable for participants aged >90 years to protect patient privacy, as the reduced frequency of individuals in this age group increased the risk of identification. As a result, it was not possible to determine whether these participants met the inclusion criteria; therefore, they were excluded from the study. The final matched study population included all eligible cases and their matched controls. In the MVP cohort, some participants were excluded due to withdrawal of their informed consent.
Extended Data Figure 1. Study inclusion and exclusion criteria for RAAS inhibitor-induced angioedema cases. AoURP, All of Us Research Program; GERA, Genetic Epidemiology Research in Adult Health and Aging; MVP, Million Veteran Program; RAAS, renin-angiotensin-aldosterone system. In the GERA cohort, the timing of RAAS inhibitor initiation was unavailable for participants aged >90 years to protect patient privacy, as the reduced frequency of individuals in this age group increased the risk of identification. As a result, it was not possible to determine whether these participants met the inclusion criteria; therefore, they were excluded from the study. The final matched study population included all eligible cases and their matched controls. In the MVP cohort, some participants were excluded due to withdrawal of their informed consent.CC BY-NC · PubMed Central
Extended Data Figure 2. Association of Black race with RAAS inhibitor-induced angioedema risk in the GERA cohort across multivariable logistic regression models 1KG-AFR, 1000 Genomes African superpopulation; clin., clinical; demogr., demographic; GERA, Genetic Epidemiology Research in Adult Health and Aging; RAAS, renin-angiotensin-aldosterone system; SDOH, social determinants of health. The inclusion of SDOH did not account for the observed association with Black race, whereas the addition of 1KG-AFR-like genetic similarity completely abrogated the race effect.
Extended Data Figure 2. Association of Black race with RAAS inhibitor-induced angioedema risk in the GERA cohort across multivariable logistic regression models 1KG-AFR, 1000 Genomes African superpopulation; clin., clinical; demogr., demographic; GERA, Genetic Epidemiology Research in Adult Health and Aging; RAAS, renin-angiotensin-aldosterone system; SDOH, social determinants of health. The inclusion of SDOH did not account for the observed association with Black race, whereas the addition of 1KG-AFR-like genetic similarity completely abrogated the race effect.CC BY-NC · PubMed Central
Extended Data Figure 3. Meta-GWAS for RAAS inhibitor-induced angioedema in participants with >5% 1KG-AFR-like genetic similarity (Case: N = 1790; Control: N = 17 726) 1KG-AFR, 1000 Genomes African superpopulation; GWAS, genome-wide association study; RAAS, renin-angiotensin-aldosterone system. The −log10 association P values (vertical axis) obtained from a fixed-effects meta-analysis of GWAS summary statistics in participants with >5% 1KG-AFR-like genetic similarity across All of Us Research Program (AoURP), Genetic Epidemiology Research in Adult Health and Aging (GERA), and Million Veteran Program (MVP) cohorts against their genomic positions (horizontal axis) are displayed. The blue horizontal line indicates the prespecified threshold for a suggestive association (P = 1 × 10−5), and the red horizontal line indicates the threshold for genome-wide significance (P = 5 × 10−8).
Extended Data Figure 3. Meta-GWAS for RAAS inhibitor-induced angioedema in participants with >5% 1KG-AFR-like genetic similarity (Case: N = 1790; Control: N = 17 726) 1KG-AFR, 1000 Genomes African superpopulation; GWAS, genome-wide association study; RAAS, renin-angiotensin-aldosterone system. The −log10 association P values (vertical axis) obtained from a fixed-effects meta-analysis of GWAS summary statistics in participants with >5% 1KG-AFR-like genetic similarity across All of Us Research Program (AoURP), Genetic Epidemiology Research in Adult Health and Aging (GERA), and Million Veteran Program (MVP) cohorts against their genomic positions (horizontal axis) are displayed. The blue horizontal line indicates the prespecified threshold for a suggestive association (P = 1 × 10−5), and the red horizontal line indicates the threshold for genome-wide significance (P = 5 × 10−8).CC BY-NC · PubMed Central
Extended Data Figure 4. Cross-race meta-GWAS for RAAS inhibitor-induced angioedema. (Case: N = 4461; Control: N = 44 603) GWAS, genome-wide association study; RAAS, renin-angiotensin-aldosterone system. The −log10 association P values (vertical axis) obtained from a fixed effects, cross-race meta-analysis of GWAS summary statistics across All of Us Research Program (AoURP), Genetic Epidemiology Research in Adult Health and Aging (GERA), and Million Veteran Program (MVP) cohorts against their genomic positions (horizontal axis) are displayed. The blue horizontal line indicates the prespecified threshold for a suggestive association (P = 1 × 10−5), and the red horizontal line indicates the threshold for genome-wide significance (P = 5 × 10−8).
Extended Data Figure 4. Cross-race meta-GWAS for RAAS inhibitor-induced angioedema. (Case: N = 4461; Control: N = 44 603) GWAS, genome-wide association study; RAAS, renin-angiotensin-aldosterone system. The −log10 association P values (vertical axis) obtained from a fixed effects, cross-race meta-analysis of GWAS summary statistics across All of Us Research Program (AoURP), Genetic Epidemiology Research in Adult Health and Aging (GERA), and Million Veteran Program (MVP) cohorts against their genomic positions (horizontal axis) are displayed. The blue horizontal line indicates the prespecified threshold for a suggestive association (P = 1 × 10−5), and the red horizontal line indicates the threshold for genome-wide significance (P = 5 × 10−8).CC BY-NC · PubMed Central
Figure 1. Association of Black race with RAAS inhibitor-induced angioedema risk in the AoURP cohort across multivariable logistic regression models 1KG-AFR, 1000 Genomes African superpopulation; AoURP, All of Us Research Program; clin., clinical; demogr., demographic; RAAS, renin-angiotensin-aldosterone system; SDOH, social determinants of health. The inclusion of SDOH minimally explained the observed association with Black race, while the addition of 1KG-AFR-like genetic similarity completely abrogated the race effect.
Figure 1. Association of Black race with RAAS inhibitor-induced angioedema risk in the AoURP cohort across multivariable logistic regression models 1KG-AFR, 1000 Genomes African superpopulation; AoURP, All of Us Research Program; clin., clinical; demogr., demographic; RAAS, renin-angiotensin-aldosterone system; SDOH, social determinants of health. The inclusion of SDOH minimally explained the observed association with Black race, while the addition of 1KG-AFR-like genetic similarity completely abrogated the race effect.CC BY-NC · PubMed Central
Figure 2. Meta-GWAS for RAAS inhibitor-induced angioedema in the Black participant group. (Case: N = 1657; Control: N = 16 567) GWAS, genome-wide association study; RAAS, renin-angiotensin-aldosterone system. The −log10 association P values (vertical axis) obtained from a fixed-effects meta-analysis of GWAS summary statistics in the Black participant groups across the All of Us Research Program (AoURP), Genetic Epidemiology Research in Adult Health and Aging (GERA), and Million Veteran Program (MVP) cohorts against their genomic positions (horizontal axis) are displayed. Significant associations were identified for variants near BDKRB2. The blue horizontal line indicates the prespecified threshold for a suggestive association (P = 1 × 10−5), and the red horizontal line indicates the threshold for genome-wide significance (P = 5 × 10−8).
Figure 2. Meta-GWAS for RAAS inhibitor-induced angioedema in the Black participant group. (Case: N = 1657; Control: N = 16 567) GWAS, genome-wide association study; RAAS, renin-angiotensin-aldosterone system. The −log10 association P values (vertical axis) obtained from a fixed-effects meta-analysis of GWAS summary statistics in the Black participant groups across the All of Us Research Program (AoURP), Genetic Epidemiology Research in Adult Health and Aging (GERA), and Million Veteran Program (MVP) cohorts against their genomic positions (horizontal axis) are displayed. Significant associations were identified for variants near BDKRB2. The blue horizontal line indicates the prespecified threshold for a suggestive association (P = 1 × 10−5), and the red horizontal line indicates the threshold for genome-wide significance (P = 5 × 10−8).CC BY-NC · PubMed Central
Figure 3. Meta-GWAS for RAAS inhibitor-induced angioedema in the White participant group. (Case: N = 2565; Control: N = 25 647) GWAS, genome-wide association study; RAAS, renin-angiotensin-aldosterone system. The −log10 association P values (vertical axis) obtained from a fixed-effects meta-analysis of GWAS summary statistics in the White participant groups across All of Us Research Program (AoURP), Genetic Epidemiology Research in Adult Health and Aging (GERA), and Million Veteran Program (MVP) cohorts against their genomic positions (horizontal axis) are displayed. Significant associations were identified for variants near BDKRB2, OTULINL, and CRABP1. The blue horizontal line indicates the prespecified threshold for a suggestive association (P = 1 × 10−5), and the red horizontal line indicates the threshold for genome-wide significance (P = 5 × 10−8).
Figure 3. Meta-GWAS for RAAS inhibitor-induced angioedema in the White participant group. (Case: N = 2565; Control: N = 25 647) GWAS, genome-wide association study; RAAS, renin-angiotensin-aldosterone system. The −log10 association P values (vertical axis) obtained from a fixed-effects meta-analysis of GWAS summary statistics in the White participant groups across All of Us Research Program (AoURP), Genetic Epidemiology Research in Adult Health and Aging (GERA), and Million Veteran Program (MVP) cohorts against their genomic positions (horizontal axis) are displayed. Significant associations were identified for variants near BDKRB2, OTULINL, and CRABP1. The blue horizontal line indicates the prespecified threshold for a suggestive association (P = 1 × 10−5), and the red horizontal line indicates the threshold for genome-wide significance (P = 5 × 10−8).CC BY-NC · PubMed Central
Figure 4. Genome-wide heterogeneity test for RAAS inhibitor-induced angioedema. RAAS, renin-angiotensin-aldosterone system. The −log10 association P values (vertical axis) obtained from genome-wide heterogeneity tests between the Black and White participant groups for genetic variants against their genomic positions (horizontal axis) are displayed. Significant associations were identified for variants near BDKRB2. The blue horizontal line indicates the prespecified threshold for a suggestive association (P = 1×10−5), and the red horizontal line indicates the threshold for genome-wide significance (P = 5 × 10−8).
Figure 4. Genome-wide heterogeneity test for RAAS inhibitor-induced angioedema. RAAS, renin-angiotensin-aldosterone system. The −log10 association P values (vertical axis) obtained from genome-wide heterogeneity tests between the Black and White participant groups for genetic variants against their genomic positions (horizontal axis) are displayed. Significant associations were identified for variants near BDKRB2. The blue horizontal line indicates the prespecified threshold for a suggestive association (P = 1×10−5), and the red horizontal line indicates the threshold for genome-wide significance (P = 5 × 10−8).CC BY-NC · PubMed Central
Figure 5. Association of Black race with RAAS inhibitor-induced angioedema risk in the AoURP cohort following polygenic score incorporation across multivariable logistic regression models AoURP, All of Us Research Program; clin., clinical; demogr., demographic; MVP, Million Veteran Program; PRSRAAS, RAAS inhibitor-induced angioedema polygenic risk score; PSHET, heterogeneity polygenic score; RAAS, renin-angiotensin-aldosterone system. The inclusion of PSHET and PRSRAAS (generated from MVP data) independently attenuated the association of Black race with RAAS inhibitor-induced angioedema risk in the AoURP cohort. When both PSHET and PRSRAAS were incorporated in the model simultaneously, the effect of Black race was further reduced.
Figure 5. Association of Black race with RAAS inhibitor-induced angioedema risk in the AoURP cohort following polygenic score incorporation across multivariable logistic regression models AoURP, All of Us Research Program; clin., clinical; demogr., demographic; MVP, Million Veteran Program; PRSRAAS, RAAS inhibitor-induced angioedema polygenic risk score; PSHET, heterogeneity polygenic score; RAAS, renin-angiotensin-aldosterone system. The inclusion of PSHET and PRSRAAS (generated from MVP data) independently attenuated the association of Black race with RAAS inhibitor-induced angioedema risk in the AoURP cohort. When both PSHET and PRSRAAS were incorporated in the model simultaneously, the effect of Black race was further reduced.CC BY-NC · PubMed Central
Figure 6. Zoom locus plot of loci reaching genome-wide significance for cross-race meta-GWAS of RAAS inhibitor-induced angioedema. GWAS, genome-wide association study; RAAS, renin-angiotensin-aldosterone system. The plots display the −log10 association P values (vertical axis) obtained from a fixed effects, cross-race meta-analysis of GWAS summary statistics across All of Us Research Program (AoURP), Genetic Epidemiology Research in Adult Health and Aging (GERA), and Million Veteran Program (MVP) cohorts against their genomic positions (horizontal axis). Results are shown for the BDKRB2 locus in the Black participant group (a), the BDKRB2 locus in the White participant group (b), and the OTULINL locus (displayed as FAM105A) in the White participant group (c) . The gray dotted horizontal line indicates the threshold for genome-wide significance (P = 5 × 10−8).
Figure 6. Zoom locus plot of loci reaching genome-wide significance for cross-race meta-GWAS of RAAS inhibitor-induced angioedema. GWAS, genome-wide association study; RAAS, renin-angiotensin-aldosterone system. The plots display the −log10 association P values (vertical axis) obtained from a fixed effects, cross-race meta-analysis of GWAS summary statistics across All of Us Research Program (AoURP), Genetic Epidemiology Research in Adult Health and Aging (GERA), and Million Veteran Program (MVP) cohorts against their genomic positions (horizontal axis). Results are shown for the BDKRB2 locus in the Black participant group (a), the BDKRB2 locus in the White participant group (b), and the OTULINL locus (displayed as FAM105A) in the White participant group (c) . The gray dotted horizontal line indicates the threshold for genome-wide significance (P = 5 × 10−8).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

The publisher hasn’t deposited this paper’s reference list.

Research works printed but not linked: 7

  1. 10.1016/j.cardfail.2010.04.004 · DOI · Paper page
  2. 10.1016/j.jacc.2013.05.019 · DOI · Paper page
  3. 2025, SLCO1B1 Functional Variants, Bilirubin, Statin-Induced Myotoxicity, and Recent Sub-Saharan African Ancestry: A Precision Medicine Health Equity Study, Clin. Pharmacol. Ther, 117, 1696, 10.1002/cpt.3624 · DOI
  4. 2024, Abstract 4147849: Extracellular Transcriptomics-driven Identification and Characterization of lncRNA LINC00989 in Heart Failure Progression, Circulation, 150, A4147849
  5. 10.1097/NAQ.0000000000000118 · DOI
  6. 2021, Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy, Pharmacoepidemiol. Drug Saf, 30, 1630, 10.1002/pds.5361 · DOI
  7. National Academies of Sciences, Engineering, and Medicine; Division of Behavioral and Social Sciences and Education; Health and Medicine Division; Committee on Population; Board on Health Sciences Policy; Committee on the Use of Race, Ethnicity, and Ancestry as Population Descriptors in Genomics Research. Using Population Descriptors in Genetics and Genomics Research: A New Framework for an Evolving Field. (National Academies Press (US), Washington (DC), 2023).

Cited by

Still being checked.

Metadata

Authors
Toda, N., Haldar, T., Teerlink, C. C., Hu, D., Danilov, P., Huntsman, S., Lu, M., Tsao, P. S., Tcheandjieu, C., Iribarren, C., Bress, A., Lynch, J. A., Ziv, E., & Oni-Orisan, A.
Affiliations
  • University of California, San Francisco (US)
  • United States Department of Veterans Affairs (US)
  • Kaiser Permanente (US)
  • Stanford Medicine (US)
  • Gladstone Institutes (US)
  • University of Utah (US)
  • Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA, USA
Venue
medRxiv
Publisher
openRxiv
Published
2026-01-08
OpenAlex
W7119472058
Cited by
0
References
0
Type
posted content
Language
en
Open access
Locations
  • medRxiv (acceptedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc)
Funders
  • National Institutes of Health
  • National Human Genome Research Institute (R01HG012824)
Topics
  • Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
angioedema, renin-angiotensin-aldosterone system inhibitors, adverse drug reactions, racial disparities, Black patients, CRABP1, bradykinin, alcohol consumption, social determinants of health, genetic factors, precision medicine, health equity, genome-wide association study, allele frequency differences, polygenic risk

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic and Social Determinants of Renin-Angiotensin-Aldosterone System Inhibitor-Induced Angioedema: A Precision Medicine Health Equity Study. https://app.cochat.ai/papers/10.64898/2026.01.06.26343530
The paper
Toda, N., Haldar, T., Teerlink, C. C., Hu, D., Danilov, P., Huntsman, S., Lu, M., Tsao, P. S., Tcheandjieu, C., Iribarren, C., Bress, A., Lynch, J. A., Ziv, E., & Oni-Orisan, A. (2026). Genetic and Social Determinants of Renin-Angiotensin-Aldosterone System Inhibitor-Induced Angioedema: A Precision Medicine Health Equity Study. medRxiv. https://doi.org/10.64898/2026.01.06.26343530

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.